Poly Medicure [POLYMED] vs Prevest Denpro [PREVEST] Detailed Stock Comparison
Poly Medicure
NSE
Loading...
Prevest Denpro
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Poly Medicure wins in 4 metrics, Prevest Denpro wins in 14 metrics, with 0 ties. Prevest Denpro appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Poly Medicure | Prevest Denpro | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 56.51 | 36.86 | Prevest Denpro |
| Price-to-Book Ratio | 7.17 | 6.35 | Prevest Denpro |
| Debt-to-Equity Ratio | 6.52 | 0.00 | Prevest Denpro |
| PEG Ratio | 250.96 | N/A | N/A |
| EV/EBITDA | 41.50 | 26.13 | Prevest Denpro |
| Profit Margin (TTM) | 20.28% | 28.81% | Prevest Denpro |
| Operating Margin (TTM) | 22.33% | 32.92% | Prevest Denpro |
| EBITDA Margin (TTM) | 22.33% | 32.92% | Prevest Denpro |
| Return on Equity | 15.99% | 18.70% | Prevest Denpro |
| Return on Assets (TTM) | 9.16% | 12.17% | Prevest Denpro |
| Free Cash Flow (TTM) | $-906.06M | $128.49M | Prevest Denpro |
| Dividend Yield | 0.14% | N/A | N/A |
| 1-Year Return | 1.13% | 3.30% | Prevest Denpro |
| Price-to-Sales Ratio (TTM) | 11.70 | 10.63 | Prevest Denpro |
| Enterprise Value | $188.15B | $5.77B | Poly Medicure |
| EV/Revenue Ratio | 11.27 | 9.16 | Prevest Denpro |
| Gross Profit Margin (TTM) | 66.56% | 86.70% | Prevest Denpro |
| Revenue per Share (TTM) | $168 | $53 | Poly Medicure |
| Earnings per Share (Diluted) | $34.11 | $15.14 | Poly Medicure |
| Beta (Stock Volatility) | 0.04 | 0.51 | Poly Medicure |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Poly Medicure vs Prevest Denpro Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Poly Medicure | 2.42% | -1.51% | -11.04% | -20.44% | -12.40% | -26.34% |
| Prevest Denpro | 4.30% | 1.45% | 3.87% | 15.53% | 14.34% | -7.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Poly Medicure | 1.13% | 163.79% | 358.72% | 808.47% | 5,957.38% | 5,957.38% |
| Prevest Denpro | 3.30% | 65.82% | 110.57% | 110.57% | 110.57% | 110.57% |
Performance & Financial Health Analysis: Poly Medicure vs Prevest Denpro
| Metric | POLYMED | PREVEST |
|---|---|---|
| Market Information | ||
| Market Cap | ₹195.30B | ₹6.70B |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 143,078 | 5,120 |
| 90 Day Avg. Volume | 126,420 | 12,460 |
| Last Close | ₹1,974.10 | ₹558.00 |
| 52 Week Range | ₹1,862.05 - ₹3,357.80 | ₹393.60 - ₹686.00 |
| % from 52W High | -41.21% | -18.66% |
| All-Time High | ₹3,357.80 (Oct 28, 2024) | ₹686.00 (Jan 13, 2025) |
| % from All-Time High | -41.21% | -18.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | 0.14% |
| Quarterly Earnings Growth | 0.34% | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.29% |
| Operating Margin (TTM) | 0.22% | 0.33% |
| Return on Equity (TTM) | 0.16% | 0.19% |
| Debt to Equity (MRQ) | 6.52 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹268.63 | ₹87.89 |
| Cash per Share (MRQ) | ₹117.33 | ₹54.61 |
| Operating Cash Flow (TTM) | ₹2.40B | ₹148.17M |
| Levered Free Cash Flow (TTM) | ₹-1,657,084,800 | ₹106.82M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.14% | N/A |
| Last 12-Month Dividend | ₹3.00 | N/A |
Valuation & Enterprise Metrics Analysis: Poly Medicure vs Prevest Denpro
| Metric | POLYMED | PREVEST |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 56.51 | 36.86 |
| Forward P/E | 250.96 | N/A |
| PEG Ratio | 250.96 | N/A |
| Price to Sales (TTM) | 11.70 | 10.63 |
| Price to Book (MRQ) | 7.17 | 6.35 |
| Market Capitalization | ||
| Market Capitalization | ₹195.30B | ₹6.70B |
| Enterprise Value | ₹188.15B | ₹5.77B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.27 | 9.16 |
| Enterprise to EBITDA | 41.50 | 26.13 |
| Risk & Other Metrics | ||
| Beta | 0.04 | 0.51 |
| Book Value per Share (MRQ) | ₹268.63 | ₹87.89 |
Financial Statements Comparison: Poly Medicure vs Prevest Denpro
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | POLYMED | PREVEST |
|---|---|---|
| Revenue/Sales | ₹4.41B | ₹184.55M |
| Cost of Goods Sold | ₹1.47B | ₹24.54M |
| Gross Profit | ₹2.93B | ₹160.01M |
| Research & Development | ₹112.93M | N/A |
| Operating Income (EBIT) | ₹984.32M | ₹60.76M |
| EBITDA | ₹1.46B | ₹76.23M |
| Pre-Tax Income | ₹1.23B | ₹71.51M |
| Income Tax | ₹310.15M | ₹20.16M |
| Net Income (Profit) | ₹918.34M | ₹51.41M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | POLYMED | PREVEST |
|---|---|---|
| Cash & Equivalents | ₹86.99M | ₹608.98M |
| Total Current Assets | ₹19.17B | ₹857.16M |
| Total Current Liabilities | ₹3.70B | ₹59.62M |
| Long-Term Debt | ₹7.71M | ₹0 |
| Total Shareholders Equity | ₹27.66B | ₹1.06B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹10.41B | ₹268.13M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | POLYMED | PREVEST |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | POLYMED | PREVEST |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 143,078 | 5,120 |
| Average Daily Volume (90 Day) | 126,420 | 12,460 |
| Shares Outstanding | 101.33M | 12.00M |
| Float Shares | 33.77M | 2.61M |
| % Held by Insiders | 0.67% | 0.78% |
| % Held by Institutions | 0.19% | 0.00% |
Dividend Analysis & Yield Comparison: Poly Medicure vs Prevest Denpro
| Metric | POLYMED | PREVEST |
|---|---|---|
| Last 12-Month Dividend | ₹3.00 | N/A |
| Last 12-Month Dividend Yield | 0.14% | N/A |
| 3-Year Avg Annual Dividend | ₹2.83 | N/A |
| 3-Year Avg Dividend Yield | 0.21% | N/A |
| 3-Year Total Dividends | ₹8.50 | N/A |
| Ex-Dividend Date | Sep 19, 2024 | N/A |